Definium Therapeutics Inc (DFTX) PT Raised to $67 at Stifel

September 14, 2026 9:36 AM

Stifel analyst Paul Matteis raised the price target on Definium Therapeutics Inc (NASDAQ: DFTX) to $67.00 (from $60.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found